Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT06759259

Mannitol Administration for Delerium Prevention

Conditions: Myocardial Infarction (MI), Delirium, Intensive Care Unit, Randomised Controlled Trial

Sex: All

Ages: 65 Years – N/A

Healthy volunteers: No

Enrollment: 50

Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences

Location: Cardiology Reserch Institute Tomsk National Research Centre Tomsk Tomsk Oblast

Summary

The aim of the study is to evaluate the efficacy of adjuvant administration of mannitol for the prevention of delirium in patients with myocardial infarction.

Eligibility Criteria

Inclusion Criteria: * Age 65 and over * Myocardial infarction in the first day of illness ("pain to door" time \< 254 hours) * Serum CRP \> 25 mg/L Exclusion Criteria: * A known pathological process in the brain, psychiatric disorders * Impossibility of conducting an assessment CAM-ICU

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06759259). StuddyBuddy aggregates publicly available trial information.